Research Article
Serum Irisin Predicts Posthepatectomy Complications in Patients with Hepatocellular Carcinoma
Table 2
Comprehensive complication index (CCI), complications, and outcomes in HCC patients.
| | Variable ( or (%)) | Total () | μg/ml () | μg/ml () | value |
| | Comprehensive complication index (CCI) | | | | 0.021 | | Complications | | | | | | Peritoneal effusion | 27 (23.1%) | 6 (22.2%) | 21 (23.3%) | 0.904 | | Intra-abdominal hemorrhage | 2 (1.7%) | 1 (3.7%) | 1 (1.1%) | 0.410 | | Infectious complications | 20 (17.1%) | 3 (11.1%) | 17 (18.9%) | 0.516 | | Pulmonary infection | 15 (12.8%) | 3 (11.1%) | 12 (13.3%) | 1 | | Hepatic abscess | 3 (2.6%) | 0 (0) | 3 (3.3%) | 1 | | Sepsis | 1 (0.9%) | 0 (0) | 1 (1.1%) | 1 | | Other infections | 1 (0.9%) | 0 (0) | 1 (1.1%) | 1 | | Biliary complications | 6 (5.1%) | 0 (0) | 6 (6.7%) | 0.334 | | Bile leakage | 5 (4.3%) | 0 (0) | 5 (5.6%) | 0.478 | | Biliary stricture | 1 (0.9%) | 0 (0) | 1 (1.1%) | 1 | | Organ failure | 5 (4.3%) | 1 (3.7%) | 4 (4.4%) | 1 | | Renal failure | 3 (2.6%) | 0 (0) | 3 (3.3%) | 1 | | Liver failure | 1 (0.9%) | 0 (0) | 1 (1.1%) | 1 | | MODS | 1 (0.9%) | 1 (3.7) | 0 (0) | 0.231 | | Outcomes | | | | | | Length of ICU stay | | | | 0.593 | | Length of hospital stay (days) | | | | 0.041 | | Mortality in 3 years | 48 (41.0%) | 13 (48.1%) | 35 (38.9%) | 0.391 |
|
|
